These characteristics make GLP-1 a promising therapeutic target, with several strategies developed to enhance its effects
2 After 18 months, the WL, WL + AT, and WL + RT groups achieved weight reductions of 5.7 kg, 9.9 kg, and 10.1 kg, respectively
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas
The results paved the way for liraglutide, branded as Saxenda, to be approved in the US as a once-a-day subcutaneous injection in December 2014 and in Europe in 2015 for the treatment of chronic weight management combined with a reduced calorie diet and increased physical exercise (Molteni, Chen)
She had been asked to help validate Millipore's new instrument based on ion exchange high-performance liquid chromatography
Starting at the full dose can cause severe nausea, vomiting, and other gastrointestinal effects that may force you to stop again